37 related articles for article (PubMed ID: 5777587)
1. Jaundice and oral contraceptives.
Dooner HP; Hoyl C; Aliaga C; Parada J
Acta Hepatosplenol; 1971; 18(2):84-94. PubMed ID: 5552035
[No Abstract] [Full Text] [Related]
2. [Jaundice after ovulation inhibiting steroids].
Fritsch H; Kaess H
Med Klin; 1969 May; 64(19):894-7. PubMed ID: 5772231
[No Abstract] [Full Text] [Related]
3. Functional and morphological liver changes in women taking oral contraceptives. A clinical and ultrastructural study with special reference to the occurrence of cholestasis.
Pihl E; Rais O; Zeuchner E
Acta Chir Scand; 1968; 134(8):639-50. PubMed ID: 5713447
[No Abstract] [Full Text] [Related]
4. [Medicamentous jaundice with intrahepatic cholestasis following administration of ovulation inhibitors].
Gürakar M; Erek E; Baskir S; Ucak A
Dtsch Z Verdau Stoffwechselkr; 1967 Dec; 27(5):209-10. PubMed ID: 5595741
[No Abstract] [Full Text] [Related]
5. [Toxic hepatoses due to Gravistat].
Metzner C; Ziesenhenn K; Müller H; Kirsch WD
Z Gesamte Inn Med; 1977 Aug; 32(16):407-8. PubMed ID: 595698
[TBL] [Abstract][Full Text] [Related]
6. [Cholestatic jaundice following ovulation inhibitors].
Kaess H; Fritsch H
Geburtshilfe Frauenheilkd; 1969 Mar; 29(3):213-8. PubMed ID: 5777587
[No Abstract] [Full Text] [Related]
7. Oral contraceptives and the liver.
Metreau JM; Dhumeaux D; Berthelot P
Digestion; 1972; 7(5):318-35. PubMed ID: 4602326
[No Abstract] [Full Text] [Related]
8. Biochemical and morphological study of the liver injury induced by drugs and chemicals.
Lai MY; Sung JL; Lin WS; How SW; Yu JY; Wang TH; Chen DS
Taiwan Yi Xue Hui Za Zhi; 1979 Jun; 78(6):525-48. PubMed ID: 385805
[No Abstract] [Full Text] [Related]
9. Medical aspects of oral contraceptives.
Elgee NJ
Ann Intern Med; 1970 Mar; 72(3):409-18. PubMed ID: 4906113
[No Abstract] [Full Text] [Related]
10. Drug-induced cholestasis.
Bjornsson ES; Jonasson JG
Clin Liver Dis; 2013 May; 17(2):191-209. PubMed ID: 23540497
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular damage following the use of hormonal contraceptives].
Zielińska W; Jasiel M
Pol Arch Med Wewn; 1971 May; 46(5):617-20. PubMed ID: 4935873
[No Abstract] [Full Text] [Related]
12. [Changes in laboratory tests after treatment with a new contraceptive agent].
Cervantes LF; López Barcena J; Calderón Márquez JJ
Ginecol Obstet Mex; 1978 Apr; 43(258):285-97. PubMed ID: 80349
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
